BCRX FY 2009 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

BCRXBioCryst Pharmaceuticals, Inc.

$2B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$75M+31.9% YoY

Gross Profit

$70M93.9% margin

Operating Income

-$14M-18.4% margin

Net Income

-$13M-18.0% margin

EPS (Diluted)

$-0.35

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$142M

Total Liabilities

$56M

Stockholders' Equity

$86M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$75M	$57M	+31.9%
Gross Profit	$70M	$57M	+23.8%
Operating Income	-$14M	-$27M	+49.4%
Net Income	-$13M	-$25M	+45.6%